1 follower
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.
Industries
Headquarters
Stage
Employees
Links
William Hearl
12 members
3 members
Kineta
Leap Therapeutics
First Wave BioPharma
MedRhythms
Halo Labs
Discover companies